Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Page 1
Electrochemotherapy in Aggressive Hemangioma of the Spine: A Case Series and Narrative Literature Review.
Tedesco G, Noli LE, Griffoni C, Ghermandi R, Facchini G, Peta G, Papalexis N, Asunis E, Pasini S, Gasbarrini A. Tedesco G, et al. Among authors: gasbarrini a. J Clin Med. 2024 Feb 22;13(5):1239. doi: 10.3390/jcm13051239. J Clin Med. 2024. PMID: 38592093 Free PMC article.
Further research is needed to establish definitive protocols and long-term outcomes of electrochemotherapy in spinal hemangioma management....
Further research is needed to establish definitive protocols and long-term outcomes of electrochemotherapy in spinal hemangioma manag …
Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma.
Iezzi R, Posa A, Valente I, Contegiacomo A, Zocco MA, Pompili M, Annicchiarico BE, Ponziani FR, Basso M, Goldberg SN, Giuliante F, Gasbarrini A, Sala E; HepatoCatt Study Group. Iezzi R, et al. Among authors: gasbarrini a. Radiol Med. 2024 Mar 21. doi: 10.1007/s11547-024-01805-y. Online ahead of print. Radiol Med. 2024. PMID: 38512624
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.
Sangro B, Chan SL, Kelley RK, Lau G, Kudo M, Sukeepaisarnjaroen W, Yarchoan M, De Toni EN, Furuse J, Kang YK, Galle PR, Rimassa L, Heurgué A, Tam VC, Van Dao T, Thungappa SC, Breder V, Ostapenko Y, Reig M, Makowsky M, Paskow MJ, Gupta C, Kurland JF, Negro A, Abou-Alfa GK; HIMALAYA investigators. Sangro B, et al. Ann Oncol. 2024 Feb 19:S0923-7534(24)00049-8. doi: 10.1016/j.annonc.2024.02.005. Online ahead of print. Ann Oncol. 2024. PMID: 38382875 Free article.
Long-term survivors with STRIDE (n = 103) included participants across clinically relevant subgroups, and 57.3% (59/103) had no reported subsequent anticancer therapy. ...Results continue to support the long-term benefits of STRIDE in a diverse population, reflectiv …
Long-term survivors with STRIDE (n = 103) included participants across clinically relevant subgroups, and 57.3% (59/103) had no repor …
The Role of Diet and Nutritional Interventions for the Infant Gut Microbiome.
Catassi G, Aloi M, Giorgio V, Gasbarrini A, Cammarota G, Ianiro G. Catassi G, et al. Among authors: gasbarrini a. Nutrients. 2024 Jan 30;16(3):400. doi: 10.3390/nu16030400. Nutrients. 2024. PMID: 38337684 Free PMC article. Review.
In preterm infants the gut microbiota development is influenced by multiple factors, including the time since birth and the intake of breast milk, and interventions such as probiotics and prebiotics supplementation show promising results in reducing morbidity and mortality …
In preterm infants the gut microbiota development is influenced by multiple factors, including the time since birth and the intake of …
Prothrombin time predicts steroid response in severe alcohol-related hepatitis.
Tarli C, Mannucci S, Vecchione M, Antonelli M, Sestito L, Mancarella FA, Tosoni A, Dionisi T, Maccauro V, Sario GD, Burra P, Germani G, Gasbarrini A, Addolorato G. Tarli C, et al. Among authors: gasbarrini a. Liver Int. 2024 Mar;44(3):823-830. doi: 10.1111/liv.15835. Epub 2024 Jan 18. Liver Int. 2024. PMID: 38238897
Steroid therapy represents the main medical treatment that may reduce short-term mortality. Lille score at day 7 assesses the therapeutic response to steroid therapy. ...
Steroid therapy represents the main medical treatment that may reduce short-term mortality. Lille score at day 7 assesses the therape …
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission.
Parisio L, Settanni CR, Varca S, Laterza L, Lopetuso LR, Napolitano D, Schiavoni E, Turchini L, Fanali C, Alfieri N, Pizzoferrato M, Papa A, Pafundi PC, Armuzzi A, Gasbarrini A, Pugliese D, Scaldaferri F. Parisio L, et al. Among authors: gasbarrini a. J Gastrointestin Liver Dis. 2023 Dec 22;32(4):452-459. doi: 10.15403/jgld-5084. J Gastrointestin Liver Dis. 2023. PMID: 38147610 Free article.
Real-life data are limited especially for patients receiving long-term intravenous therapy. This study aimed to evaluate the safety and effectiveness of switching from intravenous to subcutaneous vedolizumab in a large cohort of patients with stable clinical remission. ... …
Real-life data are limited especially for patients receiving long-term intravenous therapy. This study aimed to evaluate the safety a …
A pharmacokinetic evaluation of tenapanor for the treatment of irritable bowel syndrome with constipation: an update of the literature.
Currò D, Ianiro G, Gasbarrini A. Currò D, et al. Among authors: gasbarrini a. Expert Opin Drug Metab Toxicol. 2023 Dec;19(12):889-894. doi: 10.1080/17425255.2023.2294937. Epub 2024 Jan 12. Expert Opin Drug Metab Toxicol. 2023. PMID: 38108081 Review.
Increased fecal sodium and water excretion do not appear to expose patients to short- and long-term hydro-electrolyte imbalances....
Increased fecal sodium and water excretion do not appear to expose patients to short- and long-term hydro-electrolyte imbalances....
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection.
Pelizzaro F, Trevisani F, Simeon V, Vitale A, Cillo U, Piscaglia F, Missale G, Sangiovanni A, Foschi FG, Cabibbo G, Caturelli E, Di Marco M, Azzaroli F, Brunetto MR, Raimondo G, Vidili G, Guarino M, Gasbarrini A, Campani C, Svegliati-Baroni G, Giannini EG, Mega A, Masotto A, Rapaccini GL, Magalotti D, Sacco R, Nardone G, Farinati F; Italian Liver Cancer (ITA.LI.CA) group. Pelizzaro F, et al. Among authors: gasbarrini a. Liver Int. 2023 Dec;43(12):2762-2775. doi: 10.1111/liv.15719. Epub 2023 Sep 27. Liver Int. 2023. PMID: 37753540
CONCLUSIONS: Despite the high recurrence rate, LR for single HCC 5 cm offers excellent long-term survival. Non-transplantable recurrence is predicted by HCC size and AFP levels, among pre-operatively available variables. ...
CONCLUSIONS: Despite the high recurrence rate, LR for single HCC 5 cm offers excellent long-term survival. Non-transplantable recurre …
Shear Wave Dispersion in Chronic Liver Disease: From Physical Principles to Clinical Usefulness.
Garcovich M, Paratore M, Ainora ME, Riccardi L, Pompili M, Gasbarrini A, Zocco MA. Garcovich M, et al. Among authors: gasbarrini a. J Pers Med. 2023 Jun 2;13(6):945. doi: 10.3390/jpm13060945. J Pers Med. 2023. PMID: 37373934 Free PMC article. Review.
Improved B-mode imaging (3D and 4D), contrast-enhanced US (CEUS) and especially US-based elastography techniques have created the concept of multiparametric ultrasound (MP-US), a term borrowed from radiological sectional imaging. Among the new elastography techniques, shea …
Improved B-mode imaging (3D and 4D), contrast-enhanced US (CEUS) and especially US-based elastography techniques have created the concept of …
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience.
Borrelli de Andreis F, Boškoski I, Mascagni P, Schepis T, Bianchi A, Schinzari G, Annicchiarico BE, Quero G, Tortora G, Alfieri S, Gasbarrini A, Costamagna G, Spada C, Attili F. Borrelli de Andreis F, et al. Among authors: gasbarrini a. Pancreatology. 2023 Aug;23(5):543-549. doi: 10.1016/j.pan.2023.05.004. Epub 2023 May 22. Pancreatology. 2023. PMID: 37236853 Free article.
CONCLUSIONS: Data from this case series suggest that EUS-RFA is a feasible and safe therapeutic approach for pancreatic insulinomas in patients unwilling or unable to undergo surgery with medium-term efficacy....
CONCLUSIONS: Data from this case series suggest that EUS-RFA is a feasible and safe therapeutic approach for pancreatic insulinomas in patie …
117 results